Health In Tech Inc. (NASDAQ: HIT) announced a private investment in public equity (PIPE) that will raise approximately $7.0 million before fees and expenses. The company will issue 5,600,000 shares of Class A common stock at $1.25 per share, with a closing date expected on or about March 27, 2026.
The proceeds are earmarked for expanding the company’s sales distribution network, accelerating technology development, supporting new product initiatives, and providing general corporate working capital. The capital injection is intended to fuel the continued growth of HIT’s AI‑enabled insurtech platform and support its strategic expansion into larger employer segments.
Health In Tech’s 2025 financial results, released on the same day, showed full‑year revenue of $33.3 million, a 71% year‑over‑year increase, and Adjusted EBITDA of $4.1 million, up 81% from the prior year. Gross margin fell from 79.2% in 2024 to 62.8% in 2025, reflecting a shift toward higher‑volume, lower‑margin business as the distribution network expands to 858 partners—a 34% increase year‑over‑year.
Management highlighted the company’s progress: “2025 was a defining year of disciplined execution and measurable platform scale for Health In Tech. We strengthened our AI‑enabled underwriting marketplace, expanded carrier, broker, and TPA integrations, and further automated core insurance workflows to drive efficiency and margin scalability.” CEO Tim Johnson added, “As we enter 2026, our focus is on advancing a fully integrated marketplace model that expands beyond underwriting to include additional services such as claims administration and administrative cost‑containment solutions.” He also noted, “Our advantage is not just the AI model itself, it is the combination of proprietary data and integrated workflow and distribution.”
The company projects full‑year 2026 revenue between $45 million and $50 million, representing a 35%‑50% year‑over‑year growth from 2025. New product initiatives include over 100 pre‑configured stop‑loss programs launched in January 2026 and a three‑year rate‑stabilization program in development. Partnerships with Ciklum and Benefit Re are accelerating platform development and expanding product offerings.
The PIPE provides the liquidity needed to sustain HIT’s rapid revenue growth and operational scaling while maintaining focus on high‑margin service offerings. By strengthening its distribution network, advancing its AI platform, and expanding into larger employer segments, the company is positioning itself for continued market share gains in the health‑insurance technology space.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.